These findings suggest that the ratio at which c-Abl and p53 are expressed may be a more relevant predictor of TTK overexpression; they also indicate that discordant expression profiles between c-Abl and p53 may participate in driving the progression of HER2+ breast cancers as well. This evidence concerns the gene ERBB2 and breast cancer.